Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

ZEPU-2000 Limb Rehabilitation Trainer Study (ZEPU2000RCT)

NCT07749612 · Bangladesh Medical University · Updated 11 Sept 2026

What is being tested
ZEPU-2000A; ZEPU-2000D; ZEPU-2000E; Standard Rehabilitation Care
For
Stroke; Incomplete Spinal Cord Injury (SCI); Traumatic Brain Injury; Upper Extremity Motor Dysfunction; Lower Extremity Motor Dysfunction
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 60 years. About 36 people. The full rules are on the registry page.
Where
Bangladesh
When
Starts or started 1 Aug 2026, ends Dec 2026. Registered 6 Aug 2026.
Results
None posted yet.

In the researchers' words

The goal of this clinical trial is to learn whether the ZEPU-2000A, ZEPU-2000D and ZEPU-2000E robotic rehabilitation trainers help people with weakness or movement problems in their arms and legs. These devices are used to guide repeated arm and leg movements as part of rehabilitation therapy. The study will also look at whether the devices are safe to use. The main questions it aims to answer are: Is training with the ZEPU-2000 devices safe, and how well do patients tolerate and stick with the training sessions? Does adding robotic training to usual rehabilitation improve muscle strength, joint movement, balance, walking, and daily function more than usual rehabilitation alone? Researchers will compare a group receiving robotic-assisted rehabilitation plus usual care to a group receiving usual rehabilitation care alone, to see whether the robotic devices provide added benefit. Participants will: Be adults aged 18-60 with arm and/or leg movement problems caused by stroke, incomplete spinal cord injury, traumatic brain injury, or an orthopedic condition Attend training sessions 3 times a week for 12 weeks (about 36 sessions total), each lasting approximately 45 minutes Undergo assessments of strength, movement, balance, and daily function at the start of the study and every 2 weeks throughout the 12-week period Be monitored for any side effects or safety concerns, such as…
ClinicalTrials.gov, NCT07749612

Sites

  • Bangladesh Medical UniversityDhaka, Bangladesh